A Case Series of Serious Adverse Events Following Anti-VEGF Intravitreal Injections
Although generally safe and commonly used in clinical practice, physicians must be aware of the risks of anti-VEGF therapy and must remain vigilant regarding patient selection and risk-benefit considerations.
Authors
- Gabriela Udrea
- Gabriela Mușat (ORCID: https://orcid.org/0000-0001-6731-3341)
- Iustina Popescu (ORCID: https://orcid.org/0000-0002-5252-088X)
- Andreea Alexandra Mihaela Muşat
- Ovidiu Mușat
- Cornel Ştefan
- Nicoleta Zamfiroiu-Avidis
- Schmitzer Andreea
Institutions
- Carol Davila University of Medicine and Pharmacy (RO)
- Clinical Emergency Hospital Bucharest (RO)
- Centro Laser (IT)
Publication Details
- Journal
- Romanian Journal of Ophthalmology
- Published
- 2025-09-15
- DOI
- https://doi.org/10.22336/rjo.2025.70
- Primary Topic
- Retinal and Macular Surgery
- Type
- article
- Field-Weighted Citation Impact
- 0.00